Home › Asset managers › PENN SERIES FUNDS INC › 2024-2025 › Against the board
Two kinds of vote are listed: a board-sponsored proposal PENN SERIES FUNDS INC voted AGAINST or withheld on, and a shareholder proposal it voted FOR. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
2,771 proposals.
| Company | Meeting | Proposal | Category | On the ballot from | PENN SERIES FUNDS INC voted | Funds |
|---|---|---|---|---|---|---|
| ACM Research, Inc. | 2025-06-12 | Election of Directors: Haiping Dun | Director Elections | Board | ABSTAIN | 1 |
| ADC Therapeutics SA | 2024-11-11 | Approving amendments to Article 4a of the articles of association to increase the Company's capital range The Board of Directors proposes that the amendments to Article 4a of the articles of association to increase the Company's capital range be approved. | Capital Structure | Board | AGAINST | 1 |
| ADC Therapeutics SA | 2024-11-11 | Approving amendments to Article 4c of the articles of association to Increase the Company's conditional share capital for financing, acquisitions and other purposes The Board of Directors proposes that the amendments to Article 4c of the articles of association to increase the Company's conditional share capital for financing, acquisitions and other purposes be approved. | Capital Structure | Board | AGAINST | 1 |
| ADC Therapeutics SA | 2025-06-03 | Approving amendments to article 4b of the articles of association to increase the Company's conditional share capital for employee participation The Board of Directors is proposing that the amendments to article 4b paragraph 1 of the articles of association to increase the Company's conditional share capital for employee participation from 9,547,482 common shares (CHF 763,798.56) to 12,776,259 common shares (CHF 1,022,100.72) be approved, as follows (amendment underlined for ease of reference): "The share capital may be increased in an amount not to exceed CHF 1,022,100.72 through the issuance of up to 12,776,259 fully paid in registered shares with a par value of CHF 0.08 per share through the direct or indirect issuance of shares, or through the exercise or mandatory exercise of rights to acquire shares or through obligations to acquire shares, which were granted to or imposed on members of the Board of Directors, members of the executive management, employees, contractors or consultants of the Company or its group companies, or other persons providing services to the Company or its group companies." | Capital Structure | Board | AGAINST | 1 |
| ADC Therapeutics SA | 2025-06-03 | Approving an amendment to increase the number of shares authorized under the 2019 Equity Incentive Plan The Board of Directors is proposing that an amendment to increase the number of shares authorized under 2019 Equity Incentive Plan be approved. | Compensation | Board | AGAINST | 1 |
| ADC Therapeutics SA | 2025-06-03 | Approving, on a binding basis under Swiss law, the compensation of the Board of Directors and the Executive Committee The Board of Directors proposes that the maximum aggregate amount of compensation for the members of the Board of Directors for the period between the Annual Meeting and the 2026 annual general meeting of Shareholders be set at $2,300,000. | Compensation | Board | AGAINST | 1 |
| ADMA Biologics, Inc. | 2025-06-04 | To elect the following Class III directors for a term expiring at the 2028 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Jerrold B. Grossman D.P.S. | Director Elections | Board | ABSTAIN | 1 |
| ADT Inc. | 2025-05-21 | Advisory vote to approve the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 1 |
| AEON Co., Ltd. | 2025-05-28 | Elect Director Okada, Motoya | Director Elections | Board | AGAINST | 1 |
| AEON Co., Ltd. | 2025-05-28 | Elect Director Tsukamoto, Takashi | Director Elections | Board | AGAINST | 1 |
| AG Mortgage Investment Trust, Inc. | 2025-05-05 | Election of Directors: Nicholas Smith | Director Elections | Board | ABSTAIN | 1 |
| AIB Group plc | 2025-05-01 | Elect Philip Hobbs, a Shareholder Nominee, as a Director | Director Elections | Board | AGAINST | 1 |
| AMC Networks Inc. | 2025-06-05 | Election of the following nominees as Directors: Leonard Tow | Director Elections | Board | ABSTAIN | 1 |
| AMC Networks Inc. | 2025-06-05 | Vote on Proposal to Approve the Company's Amended and Restated 2016 Employee Stock Plan | Compensation | Board | AGAINST | 1 |
| AMC Networks Inc. | 2025-06-05 | Vote on Proposal to Approve the Company's Redomestication to the State of Nevada by Conversion | Extraordinary Transactions | Board | AGAINST | 1 |
| AMETEK, Inc. | 2025-05-07 | Election of Directors for a term of three years: Dean Seavers | Director Elections | Board | AGAINST | 1 |
| ANA HOLDINGS INC. | 2025-06-27 | Appoint Statutory Auditor Kikuchi, Shin | Compensation | Board | AGAINST | 1 |
| ANA HOLDINGS INC. | 2025-06-27 | Elect Director Katanozaka, Shinya | Director Elections | Board | AGAINST | 1 |
| ANSYS, Inc. | 2025-06-27 | Election of Seven Directors for One-Year Terms: Ravi Vijayaraghavan | Director Elections | Board | AGAINST | 1 |
| ANZ Group Holdings Limited | 2024-12-19 | Elect Christine Elizabeth O'Reilly as Director | Director Elections | Board | AGAINST | 1 |
| APA Group | 2024-10-24 | Approve Conditional Spill Resolution | Compensation | Board | AGAINST | 1 |
| APA Group | 2024-10-24 | Elect David Lamont as Director | Director Elections | Board | AGAINST | 1 |
| APL Apollo Tubes Limited | 2024-09-26 | Reelect Ashok Kumar Gupta as Director | Director Elections | Board | AGAINST | 1 |
| APL Apollo Tubes Limited | 2024-09-26 | Reelect Sanjay Gupta as Director | Director Elections | Board | AGAINST | 1 |
| APL Apollo Tubes Limited | 2025-01-21 | Approve Reappointment and Remuneration of Sanjay Gupta as Chairman and Managing Director | Compensation | Board | AGAINST | 1 |
| ARS Pharmaceuticals, Inc. | 2025-06-25 | To elect the four nominees for Class II director named in the proxy statement to serve for three-year terms until the 2028 Annual Meeting of Stockholders: Richard Lowenthal | Director Elections | Board | ABSTAIN | 1 |
| ASP Isotopes Inc. | 2024-11-20 | Approval of the Quantum Leap Energy LLC 2024 Equity Incentive Plan, as amended. | Compensation | Board | AGAINST | 1 |
| ASP Isotopes Inc. | 2024-11-20 | Election of directors to serve as Class II directors for a three-year term: Duncan Moore, Ph.D. | Director Elections | Board | ABSTAIN | 1 |
| AST Spacemobile, Inc. | 2024-09-10 | To elect ten directors to the Company's Board of Directors for a term expiring at the Company's 2025 Annual Meeting of Stockholders: Abel Avellan | Director Elections | Board | ABSTAIN | 1 |
| AST Spacemobile, Inc. | 2025-06-06 | To elect eleven directors to the Company's Board of Directors for a term expiring at the Company's 2026 Annual Meeting of Stockholders: Abel Avellan | Director Elections | Board | ABSTAIN | 1 |
| ASX Limited | 2024-10-28 | Approve Remuneration Report | Compensation | Board | AGAINST | 1 |
| ASX Limited | 2024-10-28 | Elect Philip Galvin as Director | Director Elections | Board | AGAINST | 1 |
| ASX Limited | 2024-10-28 | Elect Robert Caisley as Director | Director Elections | Board | AGAINST | 1 |
| AVITA Medical, Inc. | 2025-06-04 | To approve (a) the 2020 Omnibus Incentive Plan Amended and Restated (the "Plan"), the terms of which are summarized in this Proxy Statement; and (b) for purposes of ASX Listing Rule 7.2 Exception 13(b), which provides an exception to ASX Listing Rule 7.1, the issuance of the Company's equity securities under the Plan, in accordance with its terms and conditions, for a period of up to three years from the date of stockholder approval. | Compensation | Board | AGAINST | 1 |
| AVITA Medical, Inc. | 2025-06-04 | To approve the grant of 10,022 restricted stock units to acquire shares of Common Stock and the grant of 4,295 options to acquire shares of Common Stock to Suzanne Crowe on the terms and conditions set out in this Proxy Statement, pursuant to and for the purposes of ASX Listing Rule 10.11; | Compensation | Board | AGAINST | 1 |
| AVITA Medical, Inc. | 2025-06-04 | To approve the grant of 10,022 restricted stock units to acquire shares of the Company's common stock ("Common Stock") and the grant of 4,295 options to acquire shares of Common Stock to Lou Panaccio on the terms and conditions set out in the Proxy Statement, pursuant to and for the purposes of ASX Listing Rule 10.11; | Compensation | Board | AGAINST | 1 |
| AVITA Medical, Inc. | 2025-06-04 | To approve the grant of 520,000 options to acquire shares of Common Stock to the Company's Chief Executive Officer, James Corbett, on the terms and conditions set out in this Proxy Statement, pursuant to and for the purposes of ASX Listing Rule 10.11; | Compensation | Board | AGAINST | 1 |
| AZZ Inc. | 2024-07-09 | Election of Directors: Carol R. Jackson | Director Elections | Board | AGAINST | 1 |
| Abacus Global Management, Inc. | 2025-06-12 | Election of the three Class II Director Nominees: Karla Radka | Director Elections | Board | ABSTAIN | 1 |
| Abacus Global Management, Inc. | 2025-06-12 | Election of the three Class II Director Nominees: Mary Beth Schulte | Director Elections | Board | ABSTAIN | 1 |
| AbbVie Inc. | 2025-05-09 | Election of Class I Directors: Brett J. Hart | Director Elections | Board | AGAINST | 1 |
| AbbVie Inc. | 2025-05-09 | Election of Class I Directors: Edward J. Rapp | Director Elections | Board | AGAINST | 1 |
| AbbVie Inc. | 2025-05-09 | Election of Class I Directors: Thomas C. Freyman | Director Elections | Board | AGAINST | 1 |
| Abu Dhabi Commercial Bank | 2025-02-27 | Elect Ayshah Al Hallami as Director | Director Elections | Board | ABSTAIN | 1 |
| Abu Dhabi Commercial Bank | 2025-02-27 | Elect Huseen Al Nuwees as Director | Director Elections | Board | ABSTAIN | 1 |
| Abu Dhabi Commercial Bank | 2025-02-27 | Elect Khalid Khouri as Director | Director Elections | Board | ABSTAIN | 1 |
| Abu Dhabi Commercial Bank | 2025-02-27 | Elect Sultan Al Dhahiri as Director | Director Elections | Board | ABSTAIN | 1 |
| Abu Dhabi Commercial Bank | 2025-02-27 | Elect Zayid Al Nahayan as Director | Director Elections | Board | ABSTAIN | 1 |
| Abu Dhabi Commercial Bank | 2025-02-27 | Ratify the Appointment of Ahmed Al Mazrouee as Director | Director Elections | Board | AGAINST | 1 |
| Abu Dhabi Commercial Bank | 2025-02-27 | Ratify the Appointment of Carlos Obeed as Director | Director Elections | Board | AGAINST | 1 |
| Abu Dhabi Commercial Bank | 2025-02-27 | Ratify the Appointment of Fatimah Al Naeemi as Director | Director Elections | Board | AGAINST | 1 |
| Abu Dhabi Commercial Bank | 2025-02-27 | Ratify the Appointment of Khaldoun Al Mubarak as Director | Director Elections | Board | AGAINST | 1 |
| Abu Dhabi Commercial Bank | 2025-02-27 | Ratify the Appointment of Khalid Al Suweedi as Director | Director Elections | Board | AGAINST | 1 |
| Abu Dhabi Commercial Bank | 2025-02-27 | Ratify the Appointment of Saeed Al Mazrouee as Director | Director Elections | Board | AGAINST | 1 |
| Accenture plc | 2025-02-06 | Appointment of the following nominees to the Board of Directors: Arun Sarin | Director Elections | Board | AGAINST | 1 |
| Accenture plc | 2025-02-06 | Appointment of the following nominees to the Board of Directors: Julie Sweet | Director Elections | Board | AGAINST | 1 |
| Acciona SA | 2025-06-25 | Advisory Vote on Remuneration Report | Compensation | Board | AGAINST | 1 |
| Acciona SA | 2025-06-25 | Approve Remuneration Policy | Compensation | Board | AGAINST | 1 |
| Acciona SA | 2025-06-25 | Reelect Carlo Clavarino as Director | Director Elections | Board | AGAINST | 1 |
| Acciona SA | 2025-06-25 | Reelect Maite Arango Garcia-Urtiaga as Director | Director Elections | Board | AGAINST | 1 |
| Accolade, Inc. | 2024-08-06 | Election of Directors: Michael Hilton | Director Elections | Board | ABSTAIN | 1 |
| Accor SA | 2025-05-28 | Approve Compensation of Sebastien Bazin, Chairman and CEO | Compensation | Board | AGAINST | 1 |
| Accor SA | 2025-05-28 | Authorize Repurchase of Up to 10 Percent of Issued Share Capital | Capital Structure | Board | AGAINST | 1 |
| Accor SA | 2025-05-28 | Reelect Asma Abdulrahman Al-Khulaifi as Director | Director Elections | Board | AGAINST | 1 |
| Accor SA | 2025-05-28 | Reelect Isabelle Simon as Director | Director Elections | Board | AGAINST | 1 |
| Accor SA | 2025-05-28 | Reelect Nicolas Sarkozy as Director | Director Elections | Board | AGAINST | 1 |
| Accor SA | 2025-05-28 | Reelect Qionger Jiang as Director | Director Elections | Board | AGAINST | 1 |
| Accor SA | 2025-05-28 | Reelect Sarmad Zok as Director | Director Elections | Board | AGAINST | 1 |
| Accor SA | 2025-05-28 | Reelect Ugo Arzani as Director | Director Elections | Board | AGAINST | 1 |
| Accton Technology Corp. | 2025-06-12 | Elect a Representative of Golden Tengis Co., Ltd, with Shareholder No. 192057, as Non-independent Director | Director Elections | Board | AGAINST | 1 |
| Accuray Incorporated | 2024-11-21 | To approve an amendment to our 2016 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance under such plan. | Compensation | Board | AGAINST | 1 |
| Achieve Life Sciences, Inc. | 2025-06-04 | To approve an amendment to our 2023 Non-Employee Director Equity Incentive Plan to increase the number of shares available for issuance thereunder. | Compensation | Board | AGAINST | 1 |
| Acrivon Therapeutics, Inc. | 2025-06-13 | Election of Class III Directors: Santhosh Palani, Ph.D., C.F.A. | Director Elections | Board | ABSTAIN | 1 |
| Acushnet Holdings Corp. | 2025-06-02 | Election of the following nominees for director: Ho Yeon (Aaron) Lee | Director Elections | Board | ABSTAIN | 1 |
| Acushnet Holdings Corp. | 2025-06-02 | Election of the following nominees for director: Keun Chang (Kevin) Yoon | Director Elections | Board | ABSTAIN | 1 |
| Acushnet Holdings Corp. | 2025-06-02 | Election of the following nominees for director: Yoon Soo (Gene) Yoon | Director Elections | Board | ABSTAIN | 1 |
| Advantest Corp. | 2025-06-27 | Elect Director and Audit Committee Member Kurita, Yuichi | Director Elections | Board | AGAINST | 1 |
| Adverum Biotechnologies, Inc. | 2025-06-17 | Election of Class II Directors: Patrick Machado | Director Elections | Board | ABSTAIN | 1 |
| Adverum Biotechnologies, Inc. | 2025-06-17 | To approve the amendment and restatement of the Adverum Biotechnologies, Inc. 2024 Equity Incentive Award Plan. | Compensation | Board | AGAINST | 1 |
| Adverum Biotechnologies, Inc. | 2025-06-17 | To approve the amendment of certain outstanding stock options to reduce the exercise price per share to the closing price on the date of repricing. | Compensation | Board | AGAINST | 1 |
| Aena S.M.E. SA | 2025-04-09 | Reelect Francisco Javier Marin San Andres as Director | Director Elections | Board | AGAINST | 1 |
| AeroVironment, Inc. | 2024-09-27 | To elect the board of directors' three nominees as directors: Cindy Lewis | Director Elections | Board | AGAINST | 1 |
| Aeroports de Paris ADP | 2025-05-15 | Authorize Repurchase of Up to 10 Percent of Issued Share Capital | Capital Structure | Board | AGAINST | 1 |
| Aerovate Therapeutics, Inc. | 2025-04-16 | To approve the Jade Biosciences, Inc. 2025 Stock Incentive Plan (the "Stock Plan Proposal" or "Proposal No. 5"); | Compensation | Board | AGAINST | 1 |
| Aerovate Therapeutics, Inc. | 2025-04-16 | To approve the redomestication of Aerovate from the State of Delaware to the State of Nevada by conversion (the "Redomestication Proposal" or "Proposal No. 4"); | Extraordinary Transactions | Board | AGAINST | 1 |
| Aeva Technologies, Inc. | 2025-06-20 | Election of Class I Directors: Stefan Sommer, Ph. D. | Director Elections | Board | ABSTAIN | 1 |
| Agenus Inc. | 2025-06-17 | To approve a one-time exchange modification of options to purchase shares under our 2019 EIP, our Amended and Restated 2009 Equity Incentive Plan, and our 2015 Inducement Equity Plan. | Compensation | Board | AGAINST | 1 |
| Agenus Inc. | 2025-06-17 | To approve an amendment to our Amended and Restated 2019 Equity Incentive Plan ("2019 EIP") to increase the number of shares of common stock authorized for issuance thereunder from 5,050,000 shares to 12,050,000 shares. | Compensation | Board | AGAINST | 1 |
| Agenus Inc. | 2025-06-17 | To elect Brian Corvese and Timothy Wright as Class I directors, for a term of three years expiring at the 2028 Annual Meeting of Stockholders: Brian Corvese | Director Elections | Board | ABSTAIN | 1 |
| Agilysys, Inc. | 2024-09-12 | Election of Directors: Michael A. Kaufman | Director Elections | Board | ABSTAIN | 1 |
| Agios Pharmaceuticals, Inc. | 2025-06-18 | To elect each of the two Class III director nominees set forth in the Proxy Statement, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders and until his or her respective successor is duly elected and qualified: Jacqualyn A. Fouse, Ph.D. | Director Elections | Board | ABSTAIN | 1 |
| Agree Realty Corporation | 2025-05-15 | To approve, by non-binding vote, executive compensation. | Say-on-Pay | Board | AGAINST | 1 |
| Air Liquide SA | 2025-05-06 | Reelect Aiman Ezzat as Director | Director Elections | Board | AGAINST | 1 |
| Air Liquide SA | 2025-05-06 | Reelect Bertrand Dumazy as Director | Director Elections | Board | AGAINST | 1 |
| Air Products and Chemicals, Inc. | 2025-01-23 | Election of Directors: Mantle Ridge Nominees OPPOSED by the company: Tracy McKibben | Director Elections | Board | ABSTAIN | 1 |
| Air Products and Chemicals, Inc. | 2025-01-23 | Election of Directors: Nominees RECOMMENDED by the company: Charles Cogut | Director Elections | Board | ABSTAIN | 1 |
| Air Products and Chemicals, Inc. | 2025-01-23 | Election of Directors: Nominees RECOMMENDED by the company: Edward L. Monser | Director Elections | Board | ABSTAIN | 1 |
| Air Products and Chemicals, Inc. | 2025-01-23 | Election of Directors: Nominees RECOMMENDED by the company: Lisa A. Davis | Director Elections | Board | ABSTAIN | 1 |
| AirSculpt Technologies, Inc. | 2025-05-07 | Election of Directors: Dan Sollof | Director Elections | Board | AGAINST | 1 |
| Airtac International Group | 2025-05-21 | Elect WANG SHIH CHUNG, with Shareholder No. F121821XXX, as Non-independent Director | Director Elections | Board | AGAINST | 1 |
← Previous Page 3 of 28 Next →
← Back to PENN SERIES FUNDS INC 2024-2025 overview
Built 2026-10-04 from SEC Form N-PX filings.